Home » Topics » Regulatory » Patents

Patents
RSS

Institute of Materia Medica of Beijing patents deoxytylophorinine derivatives

Oct. 21, 2016

Incyte presents LSD1 inhibitors

Oct. 20, 2016

Texas A&M University develops pateamine A analogues

Oct. 20, 2016

Takeda Pharmaceutical describes ACC1 inhibitors

Oct. 20, 2016

Shionogi discloses ACC2 inhibitors

Oct. 20, 2016

Merck & Co. patents TrK-A inhibitors

Oct. 20, 2016

Arisan Therapeutics presents RNA polymerase inhibitors

Oct. 19, 2016

Celon Pharma develops PI3Kdelta inhibitors

Oct. 19, 2016

Enanta Pharmaceuticals describes FXR agonists

Oct. 19, 2016

Shenyang Sunshine Pharmaceutical discloses EGLN1 inhibitors

Oct. 19, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...